Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group

[1]  Charles M. Miller,et al.  Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis. , 2017, The lancet. Gastroenterology & hepatology.

[2]  G. Spolverato,et al.  Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma , 2016, PLoS medicine.

[3]  Q. Lai,et al.  Morphology does not tell us the entire story: biological behavior improves our ability to select patients with hepatocellular carcinoma waiting for liver transplantation. , 2015, Hepatobiliary & pancreatic diseases international : HBPD INT.

[4]  Arun J. Sanyal,et al.  非アルコール性脂肪肝炎の治療薬およびバイオマーカーの開発における課題と機会 : 米国肝臓病学会(American Association for the Study of Liver Diseases)と米国食品医薬品局の合同ワークショップの知見と推奨 , 2015 .

[5]  J. Dufour,et al.  Total tumor volume and alpha‐fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation , 2015, Hepatology.

[6]  G. Spolverato,et al.  Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study. , 2015, Journal of hepatology.

[7]  Q. Lai,et al.  Neutrophil and platelet‐to‐lymphocyte ratio as new predictors of dropout and recurrence after liver transplantation for hepatocellular cancer , 2014, Transplant international : official journal of the European Society for Organ Transplantation.

[8]  R. Hirose,et al.  Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: Implications for the current organ allocation policy , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[9]  Massimo Rossi,et al.  Alpha‐fetoprotein and modified response evaluation criteria in Solid Tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[10]  E. Vittinghoff,et al.  Offer patterns of nationally placed livers by donation service area , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[11]  F. Roudot-thoraval,et al.  Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria. , 2012, Gastroenterology.

[12]  P. Berloco,et al.  Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation , 2012, Clinical transplantation.

[13]  L. Mariani,et al.  Milan criteria in liver transplantation for hepatocellular carcinoma: An evidence‐based analysis of 15 years of experience , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[14]  J. Bruix,et al.  Management of hepatocellular carcinoma: An update , 2011, Hepatology.

[15]  José Antonio Lozano,et al.  Sensitivity Analysis of k-Fold Cross Validation in Prediction Error Estimation , 2010, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[16]  N. Kneteman,et al.  The estimated number of patients with hepatocellular carcinoma selected for liver transplantation using expanded selection criteria , 2009, Transplant international : official journal of the European Society for Organ Transplantation.

[17]  J. Trotter,et al.  Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[18]  V. Mazzaferro.  Results of liver transplantation: With or without milan criteria? , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[19]  M. Reddy,et al.  Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma. , 2007, Transplantation.

[20]  Douglas G Altman,et al.  Dichotomizing continuous predictors in multiple regression: a bad idea , 2006, Statistics in medicine.

[21]  J. Bruix,et al.  Management of hepatocellular carcinoma , 2005, Hepatology.

[22]  M. Stone.  Akaike's Criteria , 2005 .

[23]  M. Rugge,et al.  Liver Transplantation for the Treatment of Moderately or Well-Differentiated Hepatocellular Carcinoma , 2004, Annals of surgery.

[24]  L Pagliaro,et al.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. , 2001, Journal of hepatology.

[25]  A. Venook,et al.  Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival , 2001, Hepatology.

[26]  ndrea,et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.

[27]  I. Endo,et al.  The Tumor Burden Score: A New “Metro-ticket” Prognostic Tool For Colorectal Liver Metastases Based on Tumor Size and Number of Tumors , 2018, Annals of surgery.

[28]  B. Choi,et al.  Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings. , 2015, Radiology.

[29]  Su Shu-hui.  Brief introduction to 2012 EASL-EORTC Clinical Practice Guidelines on the management of hepatocellular carcinoma , 2012 .

[30]  L. Mariani,et al.  Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. , 2009, The Lancet. Oncology.

[31]  D. Woodfield.  Hepatocellular carcinoma. , 1986, The New Zealand medical journal.